Attached files

file filename
EXCEL - IDEA: XBRL DOCUMENT - Aadi Bioscience, Inc.Financial_Report.xls
EX-31.1 - CERTIFICATION OF THE COMPANY?S PRINCIPAL EXECUTIVE OFFICER PURSUANT TO SECTION 302 - Aadi Bioscience, Inc.f10q0314ex31i_zetaacqii.htm
EX-31.2 - CERTIFICATION OF THE COMPANY?S PRINCIPAL FINANCIAL OFFICER PURSUANT TO SECTION 302 - Aadi Bioscience, Inc.f10q0314ex31ii_zetaacqii.htm
10-Q - QUARTERLY REPORT - Aadi Bioscience, Inc.f10q0314_zetaacqii.htm
EX-32.2 - CERTIFICATION OF THE COMPANY?S PRINCIPAL FINANCIAL OFFICER PURSUANT TO 18 U.S.C. SECTION 1350 - Aadi Bioscience, Inc.f10q0314ex32ii_zetaacqii.htm
 
Exhibit 32.1

CERTIFICATION OF THE COMPANY’S PRINCIPAL EXECUTIVE OFFICER
PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Zeta Acquisition Corp. II (the "Company") on Form 10-Q for the period ended March 31, 2014 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, John Pappajohn, President of the Company, certify, pursuant to 18 U.S.C. ss. 1350, as adopted pursuant to ss. 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:

(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
 
 
/s/ John Pappajohn
 
John Pappajohn
 
President
(Principal Executive Officer)
 
May 15, 2014